Replies to post #305276 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Mommy, what's a TRIFECTA?

This is a TRIFECTA honey, the first one ever for CNS disease. Now, let's go watch the cliff jumpers for a while.

Anavex Life Sciences’ product portfolio includes small drug molecule lead candidate ANAVEX®2-73 for the treatment of Alzheimer’s disease, Parkinson’s disease and Rett syndrome.

https://www.anavex.com/anavex-life-sciences-reports-data-review-by-the-independent-data-safety-monitoring-board-for-its-phase-2b-3-clinical-trial-of-anavex2-73-in-patients-with-alzheimers-disease/

[LakeshoreLeo1953]

I guess good in the sense that the assumed strength all along
of the SAFETY of the compound is confirmed is good.

Good in any other interpretation is far too subjective
for me to label as significant going forward. Corporate PR(s)
are never PROOF of much in my experience. I do, however look
forward to that PROOF.

Reaction to it will hopefully be a trading opportunity.
I think I will channel the "Clash" for the next day or two.